Josh Wolfe

Josh Wolfe co-founded Lux Capital to support scientists and entrepreneurs who pursue counter-conventional solutions to the most vexing puzzles of our time in order to lead us into a brighter future. The more ambitious the project, the better—like, say, creating matter from light.

Mr. Wolfe represents Lux on wide-ranging interdisciplinary cutting-edge tech ventures spanning aerospace and defense, automation, robotics, neuroscience, scientific tools, biotech and brain machine interfaces, including Aera, Anduril, Caja Neuroscience, Crayon, Eikon, Gandeeva, Hadrian, Impulse, Kallyope, Kymeta, Osmo, Resilience, Shapeways, Strateos, Variant, Varda and more.

Mr. Wolfe is a founding investor and board member with Bill Gates in Kymeta, making cutting-edge antennas for high-speed global satellite and space communications. Josh is a Westinghouse semi-finalist and published scientist in immunopathology, and previously worked in investment banking at Salomon Smith Barney and in capital markets at Merrill Lynch. He co-founded and funded Kurion, a contrarian bet in the unlikely business of using advanced robotics and state-of-the-art engineering and chemistry to clean up nuclear waste. It was an unmet, inevitable need with no solution in sight. The company was among the first responders to the Fukushima Daiichi disaster and later Veolia acquired Kurion for 34x Lux’s total investment. He also co-founded Variant (focused on outlier people with outlier traits in outlier parts of the world) and Osmo (focused on giving machines a sense of smell).

Mr. Wolfe has been a columnist with Forbes, an invited guest to advise the White House and Capitol Hill on emerging technologies, a term member at The Council on Foreign Relations, a Trustee of the Santa Fe Institute, Chair of Coney Island Prep charter school, where he grew up in Brooklyn.

Mr. Wolfe graduated from Cornell University with a B.S. in economics and finance.